These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 22190517

  • 1. [Influence of miR-122 on IFN-α treatment for HCV infection].
    Li SJ, Chen Z, Zhu HH.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 40(6):588-92, 652. PubMed ID: 22190517
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y, Kuzuhara H, Tokumoto Y, Konishi I, Yamashita N, Matsuura B, Michitaka K, Chung RT, Onji M.
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [Abstract] [Full Text] [Related]

  • 3. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].
    Jia YT, Wei L, Jiang D, Cong X, Fei R.
    Zhonghua Yi Xue Za Zhi; 2005 Aug 03; 85(29):2065-9. PubMed ID: 16313804
    [Abstract] [Full Text] [Related]

  • 4. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
    Jia Y, Wei L, Jiang D, Wang J, Cong X, Fei R.
    J Gastroenterol Hepatol; 2007 Aug 03; 22(8):1278-85. PubMed ID: 17565587
    [Abstract] [Full Text] [Related]

  • 5. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
    Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, Crawford JM, Nelson DR, She JX, Liu C.
    Hepatology; 2003 May 03; 37(5):1180-8. PubMed ID: 12717400
    [Abstract] [Full Text] [Related]

  • 6. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
    Aboulnasr F, Hazari S, Nayak S, Chandra PK, Panigrahi R, Ferraris P, Chava S, Kurt R, Song K, Dash A, Balart LA, Garry RF, Wu T, Dash S.
    PLoS One; 2015 May 03; 10(12):e0141655. PubMed ID: 26657215
    [Abstract] [Full Text] [Related]

  • 7. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH, Kato N, Muroyama R, Taniguchi H, Guleng B, Dharel N, Shao RX, Tateishi K, Jazag A, Kawabe T, Omata M.
    Liver Int; 2010 Feb 03; 30(2):311-8. PubMed ID: 19840259
    [Abstract] [Full Text] [Related]

  • 8. [The direct antiviral effect of interferon-gamma on hepatitis C virus replicon].
    Jia YT, Wei L, Jiang D, Cong X, Fei R.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jan 03; 14(1):7-10. PubMed ID: 16420756
    [Abstract] [Full Text] [Related]

  • 9. Interferon-alpha and ribavirin resistance of Huh7 cells transfected with HCV subgenomic replicon.
    Aus dem Siepen M, Oniangue-Ndza C, Wiese M, Ross S, Roggendorf M, Viazov S.
    Virus Res; 2007 Apr 03; 125(1):109-13. PubMed ID: 17254660
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S, Schmidt JM, Lee JH, von Wagner M, Teuber G, Roth WK.
    Hepatology; 1998 Jul 03; 28(1):245-52. PubMed ID: 9657119
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha.
    Toma S, Yamashiro T, Arakaki S, Shiroma J, Maeshiro T, Hibiya K, Sakamoto N, Kinjo F, Tateyama M, Fujita J.
    J Viral Hepat; 2009 Jul 03; 16(7):506-12. PubMed ID: 19302339
    [Abstract] [Full Text] [Related]

  • 12. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
    Liu WL, Su WC, Cheng CW, Hwang LH, Wang CC, Chen HL, Chen DS, Lai MY.
    J Infect Dis; 2007 Aug 01; 196(3):425-34. PubMed ID: 17597457
    [Abstract] [Full Text] [Related]

  • 13. Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype.
    Namba K, Naka K, Dansako H, Nozaki A, Ikeda M, Shiratori Y, Shimotohno K, Kato N.
    Biochem Biophys Res Commun; 2004 Oct 08; 323(1):299-309. PubMed ID: 15351737
    [Abstract] [Full Text] [Related]

  • 14. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
    Dash S, Prabhu R, Hazari S, Bastian F, Garry R, Zou W, Haque S, Joshi V, Regenstein FG, Thung SN.
    Liver Int; 2005 Jun 08; 25(3):580-94. PubMed ID: 15910496
    [Abstract] [Full Text] [Related]

  • 15. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
    Murao K, Imachi H, Yu X, Cao WM, Nishiuchi T, Chen K, Li J, Ahmed RA, Wong NC, Ishida T.
    Gut; 2008 May 08; 57(5):664-71. PubMed ID: 17998316
    [Abstract] [Full Text] [Related]

  • 16. Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-alpha.
    Ikeda M, Mori K, Ariumi Y, Dansako H, Kato N.
    FEBS Lett; 2009 May 06; 583(9):1434-8. PubMed ID: 19332062
    [Abstract] [Full Text] [Related]

  • 17. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J, Liu S, Xu Y, Tien P, Gao G.
    Virus Res; 2009 Apr 06; 141(1):55-62. PubMed ID: 19185598
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.